Eczema differential diagnosis: Difference between revisions

Jump to navigation Jump to search
← Older editNewer edit →
VisualWikitext
Edzelco (talk | contribs)
3,196 edits
Edzelco (talk | contribs)
3,196 edits
No edit summary
Line 9: Line 9:
==Differential Diagnosis==
==Differential Diagnosis==


*Several [[medical conditions]] can mimic [[eczema]], with overlapping features. These conditions could be due to an [[inflammatory]], [[infectious]], [[immunodeficiency]], or a [[nutritional deficiency]] problem.  
*Several [[medical conditions]] can mimic [[eczema]], with overlapping features. These conditions could be due to an [[inflammation]], [[neoplasm]], [[immunodeficiency]], or a [[nutritional deficiency]] problem.  
*Table 1 summarizes these [[medical conditions]], with their corresponding expected time of presentations.
*Table 1 summarizes these [[medical conditions]], with their corresponding expected time of presentations.


Line 15: Line 15:
{| style="border: 0px; font-size: 90%; margin: 1px; width: " align="center" 1000px;"
{| style="border: 0px; font-size: 90%; margin: 1px; width: " align="center" 1000px;"
| valign="top" |
| valign="top" |
|+<big>''' Table 1. [[Differential Diagnosis]] of [[Eczema]].'''</big>
|+<big>''' Table 1. [[Differential Diagnosis]] of [[Eczema]].'''</big><ref name="pmidhttps://doi.org/10.3390/jcm4050884">{{cite journal| author=Schmoldt A, Benthe HF, Haberland G| title=Digitoxin metabolism by rat liver microsomes. | journal=Biochem Pharmacol | year= 1975 | volume= 24 | issue= 17 | pages= 1639-41 | pmid=https://doi.org/10.3390/jcm4050884 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10  }} </ref>
! align="center" style="background: #00CED1; width: 150px;" |{{fontcolor|#FFF|Type}}
! align="center" style="background: #00CED1; width: 150px;" |{{fontcolor|#FFF|Type}}
! align="center" style="background: #00CED1; width: 150px;" |{{fontcolor|#FFF|Medical Condition}}
! align="center" style="background: #00CED1; width: 150px;" |{{fontcolor|#FFF|Medical Condition}}
Line 30: Line 30:
| style="padding: 2px 2px; background: #F5F5F5;" |
| style="padding: 2px 2px; background: #F5F5F5;" |
*[[Morbiliform rash]]
*[[Morbiliform rash]]
| style="padding: 2px 2px; background: #F5F5F5;" |[[Infancy]]
| style="padding: 2px 2px; background: #F5F5F5;" |[[Infancy]].
|-
|-
| align="left" style="padding: 2px 2px; background: #F5F5F5;" |[[Contact Dermatitis]
| align="left" style="padding: 2px 2px; background: #F5F5F5;" |[[Contact Dermatitis]]
| style="padding: 2px 2px; background: #F5F5F5;" |
| style="padding: 2px 2px; background: #F5F5F5;" |
*[[Vesicular]] and [[pruritic]].
*[[Vesicular]] and [[pruritic]].
| style="padding: 2px 2px; background: #F5F5F5;" |[[Infancy]]
| style="padding: 2px 2px; background: #F5F5F5;" |[[Infancy]].
|-
 
| rowspan="1" align="center" style="padding: 2px 2px; background: #E6E6FA; font-weight: bold" |[[Neoplastic]]
| align="left" style="padding: 2px 2px; background: #F5F5F5;" |[[Cutaneous T-cell Lymphoma]]
| style="padding: 2px 2px; background: #F5F5F5;" |
*[[Eczematous]] [[patch]].
*[[Resistant]] to [[topical steroids]].
| style="padding: 2px 2px; background: #F5F5F5;" |[[Adulthood]].
|-
 
| rowspan="4" align="center" style="padding: 2px 2px; background: #E6E6FA; font-weight: bold" |[[Immunodeficiency]]
| align="left" style="padding: 2px 2px; background: #F5F5F5;" |[[Wiskott-Aldrich Syndrome]]
| style="padding: 2px 2px; background: #F5F5F5;" |
*[[Recurrent infections]], [[failure to thrive]], and resistant to [[topical steroids]].
| style="padding: 2px 2px; background: #F5F5F5;" |[[Infancy]].
|-
| align="left" style="padding: 2px 2px; background: #F5F5F5;" |[[Netherton syndrome]]
| style="padding: 2px 2px; background: #F5F5F5;" |
*[[Recurrent infections]], [[failure to thrive]], and resistant to [[topical steroids]].
| style="padding: 2px 2px; background: #F5F5F5;" |[[Infancy]].
|-
| align="left" style="padding: 2px 2px; background: #F5F5F5;" |[[Hyper IgE syndrome]]
*[[Recurrent infections]], [[failure to thrive]], and resistant to [[topical steroids]].
| style="padding: 2px 2px; background: #F5F5F5;" |[[Infancy]].
|-
| align="left" style="padding: 2px 2px; background: #F5F5F5;" |[[DOCK8]]
*[[Recurrent infections]], [[failure to thrive]], and resistant to [[topical steroids]].
| style="padding: 2px 2px; background: #F5F5F5;" |[[Infancy]].
|-
|-




| rowspan="2" align="center" style="padding: 2px 2px; background: #E6E6FA; font-weight: bold" |[[Nutritional Deficiency]]
| align="left" style="padding: 2px 2px; background: #F5F5F5;" |[[Zinc]]
| style="padding: 2px 2px; background: #F5F5F5;" |
*[[Weight loss]].
| style="padding: 2px 2px; background: #F5F5F5;" |[[Infancy]] to [[early childhood]].
|-
| align="left" style="padding: 2px 2px; background: #F5F5F5;" |[[Biotin]]
| style="padding: 2px 2px; background: #F5F5F5;" |
*[[Failure to thrive]].
| style="padding: 2px 2px; background: #F5F5F5;" |[[Infancy]] to [[early childhood]].
|-
|}
|}


Revision as of 02:33, 18 May 2022

Eczema Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Eczema from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Social Impact

Future or Investigational Therapies

Case Studies

Case #1

Eczema On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Eczema

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Eczema

CDC on Eczema

Eczema in the news

Blogs on Eczema

Directions to Hospitals Treating Eczema

Risk calculators and risk factors for Eczema

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Associate Editor(s)-in-Chief: Edzel Lorraine Co, D.M.D., M.D.

Overview

Several medical conditions can mimic eczema, with overlapping features. These conditions could be due to an inflammatory, infectious, immunodeficiency, or a nutritional deficiency problem. It is important to differentiate one from another to render proper medical treatment.[1]


Differential Diagnosis


 Table 1. Differential Diagnosis of Eczema.[1]
Type Medical Condition Manifestations Expected Time of Presentation
Inflammatory Psoriasis Adolescence to adulthood.
Viral Exanthem Infancy.
Contact Dermatitis Infancy.
Neoplastic Cutaneous T-cell Lymphoma Adulthood.
Immunodeficiency Wiskott-Aldrich Syndrome Infancy.
Netherton syndrome Infancy.
Hyper IgE syndrome Infancy.
DOCK8 Infancy.
Nutritional Deficiency Zinc Infancy to early childhood.
Biotin Infancy to early childhood.

References

  1. ↑ 1.0 1.1 Schmoldt A, Benthe HF, Haberland G (1975). "Digitoxin metabolism by rat liver microsomes". Biochem Pharmacol. 24 (17): 1639–41. PMID https://doi.org/10.3390/jcm4050884 Check |pmid= value (help).
Retrieved from "https://www.wikidoc.org/index.php?title=Eczema_differential_diagnosis&oldid=1724112"